Lacosamide

Product NDC
47335-918
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lacosamide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA205031
Marketing category
ANDA
Substance
LACOSAMIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
47335-918-181000 TABLET, FILM COATED in 1 BOTTLE (47335-918-18) 2022-03-19NoHistorical
47335-918-82180 TABLET, FILM COATED in 1 BOTTLE (47335-918-82) 2022-03-19NoHistorical
47335-918-8660 TABLET, FILM COATED in 1 BOTTLE (47335-918-86) 2022-03-19NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
These highlights do not include all the information needed to use LACOSAMIDE TABLETS safely and effectively. See full prescribing information for LACOSAMIDE TABLETS. LACOSAMIDE tablets, for oral use, CV Initial U.S. Approval: 2008Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited2024-10-14Human Prescription Drug Label13